Abstracts Archive - Page 401 of 1683 - ATC Abstracts

2020 American Transplant Congress
Comparison of Basiliximab for Induction Therapy in Kidney Transplant Recipients on Post-Operative Days 0 and 4 versus Post-Operative Days 0 and 3
C. Schardt, R. Yau, A. Burgos, C. Tunwar
Pharmacy, CHI St. Luke's Health Baylor St. Luke's Medical Center, Houston, TX
*Purpose: Current dosing recommendations for the administration of basiliximab on post-operative days (POD) 0 and 4 stem from two phase 3 renal transplant studies. Limited…
2020 American Transplant Congress
Perspectives of Nephrologists and Urologists on Financial Incentives for Altruistic Non-Directed Living Kidney Donors
F. Aziz¹, B. Hafeeq¹, J. C. Gopinathan¹, R. Narayanan¹, A. Krishnakumar¹, N. A. Uvais.²
¹Nephrology, Iqraa International Hospital and Research Centre, Calicut, India, ²Psychiatry, Iqraa International Hospital and Research Centre, Calicut, India
*Purpose: Several strategies have been suggested to remove financial barriers that can arise from donating a kidney, including payment in the form of incentives, rewards…
2020 American Transplant Congress
Dose Reduction of Anti-Thymocyte Globulin for Kidney Transplant Induction: Possible Cost Savings?
M. Chaung, E. Hollinger, M. Brokhof, N. Alvey, L. Lineberger, N. Kenyon
Rush University Medical Center, Chicago, IL
*Purpose: Based on the United Network of Organ Sharing (UNOS) annual report, there has been an increase in the number of adults ages 65-74 waiting…
2020 American Transplant Congress
Racial Disparities in Access to Kidney Transplantation in New York City
J. Torabi, M. Parides, J. A. Graham, J. P. Rocca
Montefiore Medical Center, Bronx, NY
*Purpose: Renal transplantation (RT) offers the best survival and quality of life for patients with end stage renal disease. Every effort should be made to…
2020 American Transplant Congress
Clinical Correlations Associated with Development of De Novo Donor-Specific Antibody in the First Year Following Kidney Transplant at a Single Center
J. M. Zimmerer¹, M. Basinger¹, B. A. Ringwald¹, R. Pelletier², A. Rajab¹, A. El-Hinnawi¹, M. Abdel-Rasoul¹, K. Washburn¹, G. L. Bumgardner¹
¹Ohio State University, Columbus, OH, ²Robert Wood Johnson Barnabas Health, New Brunswick, NJ
*Purpose: The development of de novo donor-specific antibody (dnDSA) portends inferior long-term graft survival. This study investigates the short-term clinical correlations associated with dnDSA that…
2020 American Transplant Congress
The Impact of Sirolimus on Weight Gain Post Heart Transplant
S. M. Gore, C. E. Raphael, K. Mara, C. Arendt, A. L. Clavell, S. A. Bernard
Mayo Clinic, Rochester, MN
*Purpose: Obesity is common after heart transplant (HT), resulting in increased risk of new onset diabetes, all-cause and cardiovascular mortality and graft failure. Immunosuppressants (ISN)…
2020 American Transplant Congress
Elucidating the Genetic Background of End Stage Renal Disease of Unknown Aetiology in Patients Listed for Kidney Transplantation
E. Leenen¹, B. Beck², A. Joerres¹, A. Weidemann¹
¹Department of Medicine I - Nephrology, Transplantation & Medical Intensive Care, Medical Center Cologne-Merheim, Cologne, Germany, ²Institute of Human Genetics University Hospital Cologne, Medical Center Cologne-Merheim, Cologne, Germany
*Purpose: The prevalence of end stage renal disease (ESRD) of unknown aetiology in adult patients accounts for almost 20% of all dialysis patients in Europe.…
2020 American Transplant Congress
Decision-Making, Motivations and the Donation Experience among HLA-Identical Living Kidney Donors at UCLA – A Qualitative Study
E. L. Wood¹, S. George², N. Kogut¹, E. Lum³, J. Veale¹
¹Urology, UCLA, Los Angeles, CA, ²Fielding School of Public Health, UCLA, Los Angeles, CA, ³Medicine, Nephrology, UCLA, Los Angeles, CA
*Purpose: Studies on motivations and decision-making processes of living donors have previously identified recipient relationship, fear of loss and altruism as important modifying factors of…
2020 American Transplant Congress
Robotic Donor Nephrectomy: A Novel Approach to Improve Living Donor Kidney Transplantation
R. Shahbazov¹, A. Popovic¹, D. Friedman², I. Bandler², S. Loerzel¹, K. Heslin², R. Hod Duvarai³, B. Gallay⁴, O. Pankewycz⁴, M. Laftavi¹
¹Surgery, Upstate Medical University, Syracuse, NY, ²College of Medicine, Upstate Medical University, Syracuse, NY, ³Pathology, Upstate Medical University, Syracuse, NY, ⁴Medicine, Upstate Medical University, Syracuse, NY
*Purpose: Robotic assisted live donor nephrectomies (RDN) have continued to gain popularity in recent years. Our purpose was to investigate the difference in outcomes between…
2020 American Transplant Congress
Comparable Outcomes for Simultaneous Liver-Kidney Transplantation with HCV NAT-Positive Donors
M. L. Samoylova¹, B. I. Shaw¹, S. J. Kesseli¹, L. McElroy¹, Y. Patel², S. Sanoff², A. S. Barbas¹
¹Surgery, Duke University Hospital, Durham, NC, ²Medicine, Duke University Hospital, Durham, NC
*Purpose: To evaluate the impact of hepatitis C virus (HCV) Nucleic Acid Amplification-positive (NAT+) donors on outcomes following simultaneous liver-kidney (SLK) transplantation.*Methods: We used the…